Published in Circulation on April 04, 2011
Gene expression profiling to study racial differences after heart transplantation. J Heart Lung Transplant (2015) 0.77
Assessment of Heart Transplant Waitlist Time and Pre- and Post-transplant Failure: A Mixed Methods Approach. Epidemiology (2016) 0.75
Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing). Circ Heart Fail (2016) 0.75
Racial differences in withdrawal of mechanical ventilation do not alter mortality in neurologically injured patients. J Crit Care (2013) 0.75
Mortality, rehospitalization, and post-transplant complications in gender-mismatched heart transplant recipients. Heart Lung (2017) 0.75
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc (2002) 15.61
Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA (2000) 10.51
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
Infection in solid-organ transplant recipients. N Engl J Med (2007) 5.47
Racial trends in the use of major procedures among the elderly. N Engl J Med (2005) 5.35
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med (2010) 4.31
What if we were equal? A comparison of the black-white mortality gap in 1960 and 2000. Health Aff (Millwood) (2005) 3.77
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med (2003) 3.61
Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med (2001) 3.52
Health disparities--less talk, more action. N Engl J Med (2005) 2.17
Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008. J Heart Lung Transplant (2008) 2.15
Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA (2001) 2.05
The health impact of resolving racial disparities: an analysis of US mortality data. Am J Public Health (2004) 1.98
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation (1998) 1.97
Racial and ethnic disparities in the use of cardiovascular procedures: associations with type of health insurance. Am J Public Health (1997) 1.97
Differences, disparities, and biases: clarifying racial variations in health care use. Ann Intern Med (2004) 1.84
Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am Heart J (1999) 1.82
Disparities in outcome for black patients after pediatric heart transplantation. J Pediatr (2005) 1.77
Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med (2005) 1.67
Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008. J Heart Lung Transplant (2008) 1.56
The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999. J Heart Lung Transplant (1999) 1.41
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation (1998) 1.38
The effect of transplant center volume on cardiac transplant outcome. A report of the United Network for Organ Sharing Scientific Registry. JAMA (1994) 1.28
The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation (2010) 1.16
Disparities in solid organ transplantation for ethnic minorities: facts and solutions. Am J Transplant (2006) 1.11
Health disparities in transplantation: focus on the complexity and challenge of renal transplantation in African Americans. Med Clin North Am (2005) 1.09
Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol (2010) 1.04
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation (2002) 1.00
Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the National Registry of Myocardial Infarction 2. Am J Cardiol (1998) 0.98
Ethnicity as a predictor of graft longevity and recipient mortality in heart transplantation. Transplant Proc (2007) 0.95
Evolving trends in risk profiles and causes of death after heart transplantation: a ten-year multi-institutional study. J Thorac Cardiovasc Surg (2003) 0.90
Is there racial disparity in outcomes after solid organ transplantation? Am J Surg (2004) 0.89
Differences in treatment of acute myocardial infarction by sex, age, and other factors (the Stanford Five-City Project). Am J Cardiol (1996) 0.87
The impact of race and HLA matching on long-term survival following cardiac transplantation. Transplant Proc (1997) 0.86
Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care. J Card Fail (2003) 0.86
Clinical and nonclinical correlates of racial and ethnic differences in recommendation patterns for coronary revascularization. Clin Cardiol (2000) 0.85
Current status of cardiac transplantation. JAMA (1998) 0.84
Factors predicting 10-year survival after heart transplantation. J Heart Lung Transplant (2005) 0.84
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med (2005) 7.46
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Cost implications of reduced work hours and workloads for resident physicians. N Engl J Med (2009) 6.42
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
HIV development assistance and adult mortality in Africa. JAMA (2012) 4.14
Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med (2010) 3.45
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2005) 3.44
Association of coronary CT angiography or stress testing with subsequent utilization and spending among Medicare beneficiaries. JAMA (2011) 3.17
Forecasting the nursing home population. Med Care (2003) 3.11
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med (2007) 3.10
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA (2007) 2.93
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm (2008) 2.75
Temporal response of the human virome to immunosuppression and antiviral therapy. Cell (2013) 2.72
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet (2008) 2.71
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Ann Intern Med (2014) 2.69
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60
Impact of the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act on abdominal ultrasonography use among Medicare beneficiaries. Arch Intern Med (2012) 2.57
Validation of a new brief physical activity survey among men and women aged 60-69 years. Am J Epidemiol (2006) 2.37
CMS reimbursement reform and the incidence of hospital-acquired pulmonary embolism or deep vein thrombosis. J Gen Intern Med (2014) 2.30
Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients. Circulation (2006) 2.24
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Differences in medical care and disease outcomes among black and white women with heart disease. Circulation (2003) 2.16
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol (2002) 2.14
Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation (2013) 2.13
AIDS and declining support for dependent elderly people in Africa: retrospective analysis using demographic and health surveys. BMJ (2010) 2.13
Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol (2012) 2.05
Popcorn lung and bronchiolitis obliterans: a critical appraisal. Int Arch Occup Environ Health (2008) 2.03
Characterizing the admixed African ancestry of African Americans. Genome Biol (2009) 2.01
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy. Circulation (2010) 2.00
The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol (2010) 1.87
Lung transplant airway hypoxia: a diathesis to fibrosis? Am J Respir Crit Care Med (2010) 1.77
Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med (2006) 1.72
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2008) 1.72
Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure. Circ Cardiovasc Qual Outcomes (2013) 1.71
The relation of price of antiretroviral drugs and foreign assistance with coverage of HIV treatment in Africa: retrospective study. BMJ (2010) 1.71
Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol (2013) 1.69
Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2013) 1.68
Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. JACC Cardiovasc Interv (2008) 1.66
Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2012) 1.66
Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease. Am J Med (2003) 1.63
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 1.63
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 1.58
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation (2010) 1.56
Pulmonary transplantation for advanced bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg (2003) 1.54
Racial disparities in survival after lung transplantation. Arch Surg (2011) 1.49
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials. J Am Coll Cardiol (2012) 1.46
Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trial. Circulation (2002) 1.46
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
Increased resource use in lung transplant admissions in the lung allocation score era. Am J Respir Crit Care Med (2015) 1.45
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 1.45
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol (2012) 1.42
Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database. Transplantation (2009) 1.41
Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries. Am J Med (2002) 1.41
Repeat coronary revascularization procedures after successful bare-metal or drug-eluting stent implantation. J Invasive Cardiol (2010) 1.40
Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? J Am Coll Cardiol (2006) 1.40
Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure. Ann Intern Med (2015) 1.39
Health-related quality of life in patients with pulmonary arterial hypertension. Chest (2004) 1.34
SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. J Biol Chem (2010) 1.29
Insulin resistance independently predicts the progression of coronary artery calcification. Am Heart J (2009) 1.26
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2010) 1.24
Expanding the orbit of primary prevention--moving beyond JUPITER. N Engl J Med (2008) 1.24
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2008) 1.21
Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation (2002) 1.16
Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J Cardiopulm Rehabil Prev (2007) 1.15
Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J (2005) 1.12
Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. Arch Intern Med (2008) 1.12
Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process. J Clin Invest (2009) 1.11
Cost effectiveness of cardiac resynchronization therapy. J Am Coll Cardiol (2005) 1.10
Underuse of evidence-based therapies. Circulation (2004) 1.06
Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults. J Phys Act Health (2010) 1.06
Quality of life and time trade-off utility measures in patients with coronary artery disease. Am Heart J (2003) 1.05
Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Am Heart J (2007) 1.05
Effects of mass media coverage on timing and annual receipt of influenza vaccination among Medicare elderly. Health Serv Res (2010) 1.05
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. J Am Coll Cardiol (2013) 1.02
A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Atherosclerosis (2007) 1.01